July 29, 2022 9News: Veterinary pathologist shares her perspective on monkeypox outbreak

Dr. MacNeill sat down with 9News reporter Jennifer Meckles to explain what she knows about monkeypox from studying past outbreaks, and its effect on animal species.

July 28, 2022 Colorado Matters: CSU scientist adds to our understanding of monkeypox

Amy MacNeill, of Colorado State University, studies pox viruses from a veterinary perspective, given that rodents so often spread the disease to people.

July 25, 2022 Q&A: What should we know about monkeypox, and what makes this outbreak different from COVID

Amy MacNeill weighed in on how worried we should be about monkeypox, the threat of zoonotic spillover, and what differentiates this outbreak from the COVID-19 pandemic.

May 20, 2021 Man’s best friend may be our best bet to cure cancer

Amy MacNeill’s work is part of a growing subfield of cancer therapy called oncolytic virus therapy, which involves using genetically modified viruses to not only kill cancer cells, but also trigger an additional immune response from the body against those same cancer cells.

May 6, 2020 Poxviruses could yield protein pathways for coronavirus vaccine

Veterinary pathologist Amy MacNeill and her team are using the vaccinia virus – used as the very first vaccine, for smallpox – to make a vaccine that would protect against coronavirus.

February 1, 2017 ‘Next generation’ delivers mind-blowing science at 2017 CVMBS Research Day

Kirsha Fredrickson, mentored by Amy MacNeill, received 3rd place for her basic science poster presentation, “Viral-mediated oncolysis of cancer cells isolated from canine tumors.”